195 related articles for article (PubMed ID: 34481211)
1. Bcl-10, trypsin and synaptophysin helps recognize acinar cell and mixed acinar neuroendocrine cell carcinoma of the pancreas on both preoperative cytological samples and needle biopsy specimens.
Manfrin E; Parisi A; Stefanizzi L; D'Onofrio M; Bernardoni L; Crino SF; Pelosi G; Pancione M; Giordano G; Sina S; Remo A
Pathol Res Pract; 2021 Oct; 226():153593. PubMed ID: 34481211
[TBL] [Abstract][Full Text] [Related]
2. BCL10 as a useful marker for pancreatic acinar cell carcinoma, especially using endoscopic ultrasound cytology specimens.
Hosoda W; Sasaki E; Murakami Y; Yamao K; Shimizu Y; Yatabe Y
Pathol Int; 2013 Mar; 63(3):176-82. PubMed ID: 23530562
[TBL] [Abstract][Full Text] [Related]
3. Carboxypeptidase A1 and regenerating islet-derived 1α as new markers for pancreatic acinar cell carcinoma.
Said S; Kurtin PJ; Nasr SH; Graham RP; Dasari S; Vrana JA; Yasir S; Torbenson MS; Zhang L; Mounajjed T; Eric Chen ZM; Lee HE; Wu TT
Hum Pathol; 2020 Sep; 103():120-126. PubMed ID: 32702400
[TBL] [Abstract][Full Text] [Related]
4. The monoclonal anti-BCL10 antibody (clone 331.1) is a sensitive and specific marker of pancreatic acinar cell carcinoma and pancreatic metaplasia.
La Rosa S; Franzi F; Marchet S; Finzi G; Clerici M; Vigetti D; Chiaravalli AM; Sessa F; Capella C
Virchows Arch; 2009 Feb; 454(2):133-42. PubMed ID: 19066953
[TBL] [Abstract][Full Text] [Related]
5. The cytologic and immunohistochemical findings of pancreatic mixed acinar-endocrine carcinoma.
Whitehair R; Stelow EB
Diagn Cytopathol; 2021 Feb; 49(2):287-294. PubMed ID: 33128511
[TBL] [Abstract][Full Text] [Related]
6. Cytomorphologic and immunophenotypical features of acinar cell neoplasms of the pancreas.
Sigel CS; Klimstra DS
Cancer Cytopathol; 2013 Aug; 121(8):459-70. PubMed ID: 23408736
[TBL] [Abstract][Full Text] [Related]
7. Gastric mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN) with pancreatic acinar differentiation: a case report.
Fujita Y; Uesugi N; Sugimoto R; Eizuka M; Matsumoto T; Sugai T
Diagn Pathol; 2019 May; 14(1):38. PubMed ID: 31077220
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic mixed acinar-neuroendocrine carcinoma, a unique diagnostic challenge on FNA cytology: A small series of two cases with literature review.
Strait AM; Sharma N; Tsapakos MJ; Vaickus LJ; Liu X
Diagn Cytopathol; 2018 Nov; 46(11):971-976. PubMed ID: 30284406
[TBL] [Abstract][Full Text] [Related]
9. Metastatic mixed acinar-neuroendocrine carcinoma of the pancreas to the liver: a cytopathology case report with review of the literature.
Lee L; Bajor-Dattilo EB; Das K
Diagn Cytopathol; 2013 Feb; 41(2):164-70. PubMed ID: 22903971
[TBL] [Abstract][Full Text] [Related]
10. A case of pancreatic mixed acinar-neuroendocrine carcinoma successfully diagnosed with endoscopic ultrasound-guided fine needle aspiration.
Niiya F; Takano Y; Azami T; Kobayashi T; Maruoka N; Wakabayashi T; Matsuo K; Tanaka K; Norose T; Ohike N; Nagahama M
Clin J Gastroenterol; 2020 Oct; 13(5):951-958. PubMed ID: 32529486
[TBL] [Abstract][Full Text] [Related]
11. Cytological findings and BCL10 expression in pancreatic acinar cell carcinoma: A Case Report.
Ohno A; Sato Y; Nakamura E; Noguchi H; Tokumitsu T; Hiyoshi M; Nanashima A; Asada Y
Diagn Cytopathol; 2017 Mar; 45(3):247-251. PubMed ID: 27860444
[TBL] [Abstract][Full Text] [Related]
12. Insulinoma-associated protein 1 (INSM1) is a useful marker for pancreatic neuroendocrine tumor.
Tanigawa M; Nakayama M; Taira T; Hattori S; Mihara Y; Kondo R; Kusano H; Nakamura K; Abe Y; Ishida Y; Okabe Y; Hisaka T; Okuda K; Fujino K; Ito T; Kawahara A; Naito Y; Yamaguchi R; Akiba J; Akagi Y; Yano H
Med Mol Morphol; 2018 Mar; 51(1):32-40. PubMed ID: 28849340
[TBL] [Abstract][Full Text] [Related]
13. Fine needle aspiration cytology of acinar cell carcinoma of the pancreas: a report of two cases.
Samuel LH; Frierson HF
Acta Cytol; 1996; 40(3):585-91. PubMed ID: 8669201
[TBL] [Abstract][Full Text] [Related]
14. Cytomorphologic, immunophenotypical and molecular features of pancreatic acinar cell carcinoma.
Sun T; Gilani S; Jain D; Cai G
Diagn Cytopathol; 2023 Nov; 51(11):674-683. PubMed ID: 37469257
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathologic characterisitics of pancreatic acinar cell carcinomas].
Ding XH; Wang ZB; Qiu XM
Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):274-278. PubMed ID: 29690667
[No Abstract] [Full Text] [Related]
16. Solid-pseudopapillary tumor of the pancreas: immunohistochemical localization of neuroendocrine markers and CD10.
Notohara K; Hamazaki S; Tsukayama C; Nakamoto S; Kawabata K; Mizobuchi K; Sakamoto K; Okada S
Am J Surg Pathol; 2000 Oct; 24(10):1361-71. PubMed ID: 11023097
[TBL] [Abstract][Full Text] [Related]
17. Non-Ductal Tumors of the Pancreas.
Dhillon J
Monogr Clin Cytol; 2020; 26():92-108. PubMed ID: 32987393
[TBL] [Abstract][Full Text] [Related]
18. Microglandular carcinoma of the pancreas.
Klimstra DS; Lonardo F
Am J Clin Pathol; 1997 Jun; 107(6):711-3. PubMed ID: 9169670
[No Abstract] [Full Text] [Related]
19. The usefulness of lymphoid enhancer-binding factor 1 and androgen receptor in diagnosing solid pseudopapillary neoplasm of the pancreas on cytopathology.
McHugh KE; Stelow EB; Harrison GP; Policarpio-Nicolas MLC
Cancer Cytopathol; 2019 Nov; 127(11):700-707. PubMed ID: 31584754
[TBL] [Abstract][Full Text] [Related]
20. Acinar cell carcinoma of the pancreas: a clinicopathologic and cytomorphologic review.
Mustafa S; Hruban RH; Ali SZ
J Am Soc Cytopathol; 2020; 9(6):586-595. PubMed ID: 32461075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
